FDA

Agriculture | Artificial Intelligence | Biotechnology | Diagnostics | Environmental | FDA | Genomics | Imaging | Infectious Disease | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health

National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’

On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…

Read More National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’
FDA | Medical Device | Neurology

Nia Therapeutics Receives FDA Breakthrough Device Designation for AI-Guided Brain Implant to Treat Memory Loss

On Mar. 18, 2026, Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device…

Read More Nia Therapeutics Receives FDA Breakthrough Device Designation for AI-Guided Brain Implant to Treat Memory Loss
Biotechnology | Cardiology | Diagnostics | FDA | Neurology | NIH | Rare Disease | Therapeutics | Women's Health

NIH invests $150 million in human-based research to reduce use of animal models

On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…

Read More NIH invests $150 million in human-based research to reduce use of animal models
Biotechnology | FDA | Infectious Disease | Pharmaceutical | Vaccine

GSK’s RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18–49 years at increased risk

On Mar. 13, 2026, GSK announced that the US Food and Drug Administration (FDA) has expanded the approved…

Read More GSK’s RSV vaccine, Arexvy, approved in US for expanded age indication in adults aged 18–49 years at increased risk
Biotechnology | Clinical Research | Diagnostics | FDA

FDA Launches New Adverse Event Monitoring System (AEMS)

On Mar. 11, 2026, the U.S. Food and Drug Administration (FDA) announced it is implementing the Adverse Event…

Read More FDA Launches New Adverse Event Monitoring System (AEMS)
Biotechnology | FDA | Infectious Disease | Therapeutics | Veterinary

FDA Issues Emergency Use Authorization for Topical Spray to Prevent and Treat New World Screwworm in Multiple Species

On Mar. 10, 2026, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for…

Read More FDA Issues Emergency Use Authorization for Topical Spray to Prevent and Treat New World Screwworm in Multiple Species
Biotechnology | FDA | Rheumatology | Therapeutics

U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for Treatment of Adults with Psoriatic Arthritis

On Mar. 6, 2026, Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has approved…

Read More U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for Treatment of Adults with Psoriatic Arthritis
Biotechnology | Disease | FDA

FDA approves Novo Nordisk’s Sogroya® as first and only once-weekly, long-acting growth hormone for three additional pediatric indications

On Feb. 27, 2026, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved three…

Read More FDA approves Novo Nordisk’s Sogroya® as first and only once-weekly, long-acting growth hormone for three additional pediatric indications
Biotechnology | Diagnostics | FDA | Infectious Disease | Neurology | NIH | U.S. Congress | USDA | Veterinary

OHSU board votes to negotiate with NIH and possibly transform its primate center into an animal sanctuary

On Feb. 9, 2026, the Oregon Health and Science University (OHSU) board of directors unanimously passed a resolution…

Read More OHSU board votes to negotiate with NIH and possibly transform its primate center into an animal sanctuary
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Vaccine | Women's Health

Large study finds COVID-19 shots don’t affect fertility

On Jan. 29, 2026, in a new study from Sweden, researchers found no statistically significant difference in rates…

Read More Large study finds COVID-19 shots don’t affect fertility
CDC | Chemistry | Dentistry | Disease | EPA | FDA | NIH | Therapeutics

US EPA moves to take action on review of fluoride in drinking water

On Jan. 28, 2026, the U.S. Environmental Protection Agency (EPA) launched the first step of its expedited review…

Read More US EPA moves to take action on review of fluoride in drinking water
COVID-19 | Diagnostics | FDA | HIV | Infectious Disease | Measles | Non-Profit Research | Polio | U.S. Congress | Vaccine | WHO | Women's Health

U.S. completes withdrawal from World Health Organization

On Jan. 22, 2026, The U.S. has finalized its withdrawal from the World Health Organization (WHO), one year…

Read More U.S. completes withdrawal from World Health Organization
Biotechnology | CDC | FDA | Infectious Disease | Influenza | NIH | Vaccine

CDC Reports Vaccinations Among Adults Age 65 and Older Declining

On Jan. 21, 2026, the Centers for Disease Control and Prevention (CDC) report the percentage of adults age…

Read More CDC Reports Vaccinations Among Adults Age 65 and Older Declining
Biotechnology | FDA | Oncology

FDA Grants Full Approval of First Oral Treatment for Lymphoma in Dogs

On Jan. 16, 2026, the U.S. Food and Drug Administration (FDA) announced it had granted full approval of…

Read More FDA Grants Full Approval of First Oral Treatment for Lymphoma in Dogs
Biotechnology | Clinical Research | Diagnostics | FDA | Genomics | Infectious Disease | Medical Device | Medicine | Non-Profit Research | Oncology | Ophthalmogy | Organ Transplant | Pharmaceutical | Rare Disease | Therapeutics | U.S. Congress | Vaccine | Women's Health

U.S. healthcare spending soars to over $5 trillion in 2024

On Jan. 14, 2026, U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion…

Read More U.S. healthcare spending soars to over $5 trillion in 2024
Diagnostics | FDA | Medical Device

US FDA to limit regulation of health and fitness wearables

On Jan. 7, 2026, the U.S. Food and Drug Administration (FDA) said that it will limit regulation of…

Read More US FDA to limit regulation of health and fitness wearables
Biotechnology | CDC | Disease | FDA | Vaccine

West Coast Health Alliance Recommends American Academy of Pediatrics Vaccine Schedule

On Jan. 5, 2026, the Acting Director of the Centers for Disease Control and Prevention signed a decision…

Read More West Coast Health Alliance Recommends American Academy of Pediatrics Vaccine Schedule
Biotechnology | Clinical Research | Disease | FDA | Therapeutics

Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America

On Jan. 5, 2026, Novo Nordisk announced that the Wegovy® pill is now available, providing those seeking help…

Read More Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
COVID-19 | FDA | Infectious Disease | Influenza | Measles | U.S. Congress | Vaccine

CMS to stop requiring states to report childhood vaccination levels

On Jan. 2, 2026, U.S. states will no longer be required to report how many children they vaccinate…

Read More CMS to stop requiring states to report childhood vaccination levels
Biotechnology | Clinical Research | Disease | FDA | Therapeutics

FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults

On Dec. 22, 2025, Novo Nordisk announced announced that the US Food and Drug Administration (FDA) has approved…

Read More FDA approves Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
Biotechnology | Cardiology | FDA | Therapeutics

FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…

Read More FDA Announces Approval of Cytokinetics’ MYQORZO™ (aficamten) for Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Biotechnology | FDA | Non-Profit Research | Oncology | Therapeutics

Space Station Research Supports New FDA-Approved Cancer Therapy

On Dec. 18, 2025, the National Aeronautics and Space Administration (NASA) announced it has opened the International Space…

Read More Space Station Research Supports New FDA-Approved Cancer Therapy
Biotechnology | Clinical Research | Disease | FDA | Therapeutics

Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management

On Dec. 18, 2025, Novo Nordisk announced the submission of a New Drug Application (NDA) to the U.S….

Read More Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
Artificial Intelligence | Biotechnology | COVID-19 | FDA | Genomics | Infectious Disease | Medical Device | Nanotechnology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Quantum | Rare Disease | U.S. Congress | Women's Health

US NIH races to fill nearly half its top roles after wave of departures

On Dec. 15, 2025, the U.S. National Institutes of Health is seeking to fill nearly half of its…

Read More US NIH races to fill nearly half its top roles after wave of departures
Biotechnology | Disease | FDA | Therapeutics

FDA Approves Two Oral Therapies to Treat Gonorrhea

On Dec. 12, 2025, the U.S. Food and Drug Administration (FDA) announced it has approved two new oral…

Read More FDA Approves Two Oral Therapies to Treat Gonorrhea
Biotechnology | FDA | Therapeutics

FDA Approves USAntibiotics’ Augmentin XR in Historic First for Expedited Review Program

On Dec. 11, 2025, USAntibiotics, the country’s only domestic manufacturer of amoxicillin (Amoxil®) and amoxicillin clavulanate (Augmentin®), announced…

Read More FDA Approves USAntibiotics’ Augmentin XR in Historic First for Expedited Review Program
FDA | Medicine | Therapeutics

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals

On Dec. 9, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved the…

Read More Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
Biotechnology | CDC | Diagnostics | Disease | FDA | Vaccine | Women's Health

US vaccine advisers say not all babies need a hepatitis B shot at birth

On Dec. 5, 2025, a federal vaccine advisory committee voted on Friday to end the longstanding recommendation that…

Read More US vaccine advisers say not all babies need a hepatitis B shot at birth
Biotechnology | CDC | Disease | FDA | Vaccine

The West Coast Health Alliance, CDPH, and Leading National Medical Organizations Continue to Recommend Hepatitis B Vaccination for Newborns

On Dec. 5, 2025, the West Coast Health Alliance (WCHA) announced that it strongly supports that hepatitis B…

Read More The West Coast Health Alliance, CDPH, and Leading National Medical Organizations Continue to Recommend Hepatitis B Vaccination for Newborns
Biotechnology | FDA | Infectious Disease | Therapeutics | Veterinary

Merck Product first in its class and the only product conditionally approved by FDA for both prevention and treatment of New World screwworm

On Dec. 4, 2025, Merck Animal Health announced the U.S. Food and Drug Administration (FDA) has granted a…

Read More Merck Product first in its class and the only product conditionally approved by FDA for both prevention and treatment of New World screwworm